Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis

Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis

US Patent 7687532 · Granted Mar 30, 2010

Estimated economic value: $87,216,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CTPS1 inhibitors and uses thereof2025
Benzimidamides compounds comprising an oxaborinin ring2023
Benzimidamides compounds comprising an oxaborinin ring2022
Benzoimidazole derivatives as PAD4 inhibitors2020
Chemical compounds2020
Compounds and methods for the enhanced degradation of targeted proteins and othe2020
Method of treating pancreatitis using 1,4-benzoxazine derivatives2020
Chemical compounds2019
Benzoimidazole derivatives as PAD4 inhibitors2019
3-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine mo2019
3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivativ2019
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors2018